FKA: I like your idea of bringing ohm's list to th

FKA: I like your idea of bringing ohm's list to the attention of the author, but given how thorough the report was, I wouldn't be surprised if he has become aware of the Investors Hangout CYDY message board, with ohm's list displayed at the top.

To broaden the scope of your suggestion, I would be disinclined to attempt to feed the author more info on Leronlimab at this point because my sense from reading the comprehensive risk/benefit analysis in the report is that Dr Jay, who is clearly referenced as a source, provided the author with all the positive info on LL that he was comfortable and/or willing to reveal.

Notice that no mention is made in the report of Dr Pestell's upcoming speech on LL blocking metastasis in breast cancer at the major European oncology conference in Vienna in July. I think there's a decent chance that Dr Jay may have held back other positive info that CYDY will be releasing between now and then. So I'm going to try to restrain my long held habit of trying to draw reasonable inferences from disjointed evidence (otherwise known as bread crumb or tea leaf reading), and let Dr Jay reveal positive developments on the timeline of his choice.

Thank you for your kind words. I think both of us are feeling very optimistic about where all of this is headed.

All the best.